Inhibitor Therapeutics INTI Cash Flow Statement (2012-2026)

OTC INTI
$0.10 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT
Reported Financials

Inhibitor Therapeutics Quarterly Cash Flow Statement

Periods 55 quarters
Latest Jun 2026

Inhibitor Therapeutics reported cash from operations of -$0.80M and free cash flow of -$0.80M for the quarter ended Jun 2026, down 37.0% year over year. This cash flow statement covers 55 quarters of results from Dec 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-0.07M-0.03M-0.10M-0.08M-0.08M-0.43M-0.54M-0.65M-0.66M-1.17M-0.68M-0.50M-0.73M-1.42M-0.63M-0.66M-0.71M-1.30M-0.69M-0.61M
Share-based Compensation
0.00M0.04M0.00M
Cash from Operations
-0.04M-0.02M-0.04M-0.06M-0.05M11.90M-0.76M-0.68M-0.56M-0.70M-1.16M-0.58M-0.72M-0.77M-1.28M-0.58M-0.76M-0.60M-1.10M-0.80M
Change in Working Capital
Change in Accured Expenses
0.03M-173.000.05M0.00M0.02M0.06M-0.19M-0.03M0.11M0.51M-0.51M-0.12M0.01M0.67M-0.64M0.05M-0.05M0.68M-0.38M-0.21M
Other Working Capital Changes
-0.00M-0.01M-0.00M-0.01M-0.00M0.01M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances
0.05M0.05M0.08M
Long-Term Debt Repayments
0.41M
Non-Current Debt
Change in Capital Stock
Net Equity Issued and Repurchased
Misc.
Cash from Financing Activities
0.05M0.05M0.08M-0.41M
Change in Cash
-0.04M-0.02M0.01M-0.01M0.03M11.90M-1.17M-0.68M-0.56M-0.70M-1.16M-0.58M-0.72M-0.77M-1.28M-0.58M-0.76M-0.60M-1.08M-0.78M
Free Cash Flow
-0.04M-0.02M-0.04M-0.06M-0.05M11.90M-0.76M-0.68M-0.56M-0.70M-1.16M-0.58M-0.72M-0.77M-1.28M-0.58M-0.76M-0.60M-1.10M-0.80M
Net Cash Flow
-0.04M-0.02M0.01M-0.01M0.03M11.90M-1.17M-0.68M-0.56M-0.70M-1.16M-0.58M-0.72M-0.77M-1.28M-0.58M-0.76M-0.60M-1.10M-0.80M

Inhibitor Therapeutics Cash Flow Statement API

Pull Inhibitor Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=INTI&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY